戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                  Poxviruses, myxoma virus and vaccinia virus specifically, utilize a
2                         Serp-1 is a secreted myxoma virus anti-inflammatory serine proteinase inhibit
3 , vaccinia virus (VACV), but also cowpox and myxoma viruses, are able to evade host IFN responses.
4 t that infection of primary murine pDCs with myxoma virus, but not with vaccinia virus, induces IFN-a
5     To characterize the ongoing evolution of myxoma virus in Australian rabbits, we used experimental
6 ock the productive replication and spread of myxoma virus in human fibroblasts.
7 from genetic knockout mice, we show that the myxoma virus-induced innate immune response requires the
8 rmacological inhibitors, we demonstrate that myxoma virus-induced type I IFN and IL-12p70 production
9 -MS based metabolomics, we characterized the myxoma virus infection induced metabolic changes in thre
10 es in cancer cells associated with oncolytic myxoma virus infection.
11                                              Myxoma virus is a rabbit poxvirus that belongs to the Le
12  Serp2 protein encoded by the leporipoxvirus myxoma virus is essential for full virulence and, like c
13                                              Myxoma virus is nonpathogenic in mice, whereas systemic
14  to those coding for interleukin-1 receptor, myxoma virus M003.2 and M004.1 genes (two copies each),
15 romelia virus macrophage host range protein, myxoma virus M011L, variola virus B22R, four ankyrin rep
16 oire of immunoregulatory proteins encoded by myxoma virus, M013 is a viral homologue of the viral pyr
17 that vaccinia virus p28 and its homologue in myxoma virus, M143R, can mediate the formation of polyub
18                    M156R, the product of the myxoma virus M156R open reading frame, has sequence simi
19  determined the crystal structures of C7 and myxoma virus M64, a C7 family member that is unable to a
20 c glioma model in immunocompetent mice after Myxoma virus (MYXV) administration.
21 irus evolution.IMPORTANCE The coevolution of myxoma virus (MYXV) and European rabbits in Australia is
22                                              Myxoma virus (MYXV) and vaccinia virus (VACV), two disti
23                           The coevolution of myxoma virus (MYXV) and wild European rabbits in Austral
24                                          The myxoma virus (MYXV) carries three tandem C7L-like host r
25              IMPORTANCE The evolution of the myxoma virus (MYXV) following its release as a biologica
26 be determined.IMPORTANCE The species jump of myxoma virus (MYXV) from the South American tapeti to th
27                                              Myxoma virus (MYXV) has been evolving in a novel host sp
28 cumented field example is the coevolution of myxoma virus (MYXV) in European rabbits.
29                                              Myxoma virus (MYXV) is a poxvirus pathogenic only for Eu
30                                              Myxoma virus (MYXV) is a rabbit-specific poxvirus that e
31                                              Myxoma virus (MYXV) is a rabbit-specific poxvirus, which
32                          The M141 protein of myxoma virus (MYXV) is a viral CD200 homolog (also calle
33 w that the replication of the model poxvirus myxoma virus (MYXV) is delayed by elevated levels of ext
34                                              Myxoma virus (MYXV) M062R is a functional homolog of the
35 ft model, we serendipitously discovered that myxoma virus (MYXV) prevented GVHD while permitting GVM.
36 e antiviral granules in the cytoplasm during myxoma virus (MYXV) replication in human cancer cells.
37              We studied a modified oncolytic myxoma virus (MYXV) that shows high efficiency for tumor
38                                              Myxoma virus (MYXV), a Leporipoxvirus, is being develope
39 e replication stage in human cancer cells of myxoma virus (MYXV), a member of the double-stranded DNA
40                The rabbit-specific poxvirus, myxoma virus (MYXV), encodes four unique ANK repeat prot
41 iruses, the distantly related leporipoxvirus myxoma virus (MYXV), which infects RIPK3-deficient hosts
42                                          The myxoma virus (MYXV)-encoded pyrin domain-containing prot
43                                 Here we test myxoma virus (MYXV)-infected tumor-specific T (T(MYXV))
44 ermediate transcription factor gene with the myxoma virus ortholog.
45                    This slows the release of myxoma virus particles from the endosomes, resulting in
46 in the orthologous M029 protein expressed by myxoma virus, plays an inhibitory role in poxvirus sensi
47 structure of M156R, the first structure of a myxoma virus protein.
48 ntagonized in a dose-dependent manner by the myxoma virus rabbit IFN-gamma receptor homolog, M-T7.
49 lular K(+) concentrations required to impact myxoma virus replication can be reached in viral lesions
50 some poxvirus serpins regulate inflammation (myxoma virus SERP1 and cowpox virus [CPV] crmA/SPI-2) or
51 cowpox virus [CPV] crmA/SPI-2) or apoptosis (myxoma virus SERP2 and CPV crmA/SPI-2), the function of
52 inhibition, we generated a novel recombinant myxoma virus (vPD1), which inhibits the PD1/PDL1 pathway
53                             In the 1950s the myxoma virus was released into European rabbit populatio
54      Among these candidates are vaccinia and myxoma viruses, which belong to the family Poxviridae an